Migalastat (Galafold) included on the Life Saving Drugs Program (LSDP)

Page last updated: 1 November 2018

Galafold is an oral treatment that has been included on the Life Saving Drugs Program (LSDP) to treat patients with Fabry disease who have an amenable mutation.